uniQure (QURE) Financials: Revenue & Earnings

QURE price $25.65 +0.68 +2.72%

Ticker
QURE
Price
$25.65
Change
+0.68 +2.72%
Market cap ?
$1.78B
P/E ?
-6.18
Forward P/E ?
24.53
Dividend yield ?
0.00%
Beta ?
0.94
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
63
Value
58
Quality
33
Growth
98

Stocklytics score rationale: value 58, quality 33, growth 98.

Financials

2016201720182019202020212022202320242025
250980001310700011284000728100037514000524002000106483000158430002711900016098000

uniQure N.V. develops treatments for patients suffering from rare and other devastating diseases in the United States. The company offers HEMGENIX that allows people living with hemophilia B to produce factor IX, which can lower the risk of bleeding. Its lead product candidate is AMT-130, a gene therapy candidate, which is in phase I/II clinical study for the treatment of Huntington’s disease. The company also…

Fair value

QURE fair value $26.86. Price $25.65. Price is about fair value.

Below fair value, but more expensive than usual. A smaller discount than on 86% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Compare QURE

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-09—-0.92—6.17M
2026-07-29-1.22-0.825.84M5.45M
2026-05-05-0.85-0.883.56M5.20M
2026-03-02-0.56-0.935.57M5.33M
2025-11-10-1.38-0.853.70M4.84M
2025-07-29-0.69-0.895.26M4.63M
2025-05-09-0.82-1.071.57M5.90M
2025-02-27-1.50-0.605.22M18.45M
2024-11-05-0.91-1.122.29M18.33M
2024-08-01-1.16-1.2411.13M6.79M
2024-05-07-1.36-1.318.48M6.23M
2024-02-28-1.53-1.546.69M5.59M
2023-11-07-1.88-1.491.41M6.11M
2023-08-01-1.442.972.42M207.71M
2023-05-09-1.63-1.025.33M28.25M
2023-02-270.15-0.89102.75M19.42M
2022-11-02-1.02-1.111.45M3.48M
2022-08-08-0.84-0.96497.00K10.19M
2022-05-02-1.00-0.671.79M17.66M
2022-02-250.17-0.8157.69M10.75M
2021-10-25-0.79-1.001.99M2.52M
2021-07-268.512.96463.87M2.52M
2021-05-10-0.91-0.89454.00K438.52K
2021-03-01-0.01-0.7834.09M—
2020-10-27-1.211.701.79M2.68M
2020-07-30-0.96-0.481.53M1.07M
2020-04-29-0.63-0.86104.00K138.67K
2020-03-02-0.97-0.782.62M79.08K
2019-10-28-0.58-0.831.05M1.46M
2019-07-29-0.83-0.752.47M2.24M
2019-04-29-0.74-0.661.14M1.09M
2019-02-28-0.59-0.661.61M1.80M
2018-11-06-0.59-0.633.15M3.31M
2018-08-08-0.57-0.623.05M3.26M
2018-04-30-0.59-0.743.48M4.36M
2018-03-14-0.91-0.682.58M2.94M
2017-11-01-0.40-0.652.26M3.56M
2017-08-08-0.83-0.864.94M4.70M
2017-05-09-0.80-0.643.32M2.74M
2017-03-15-0.58-0.529.05M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-02Kapusta Matthew CBuy21.08K$19.39408.78K
2026-07-02Kapusta Matthew CSell9.20K$44.43408.76K
2026-07-02Kapusta Matthew CSell4.28K$45.43194.53K
2026-07-02Kapusta Matthew CSell7.60K$45.89348.76K
2026-07-02Kapusta Matthew CSell21.08K$19.39408.78K
2026-06-30Abi-Saab WalidBuy10.00K$5.5955.90K
2026-06-30Abi-Saab WalidSell10.00K$46.46464.60K
2026-06-30Abi-Saab WalidSell20.00K$46.40928.00K
2026-06-30Abi-Saab WalidSell10.00K$5.5955.90K
2026-06-30Kaye JackBuy17.06K$20.18344.27K
2026-06-30Kaye JackBuy4.11K$37.00151.96K
2026-06-30Kaye JackSell17.06K$46.43792.10K
2026-06-30Kaye JackSell4.11K$46.49190.93K
2026-06-30Kaye JackSell17.06K$20.18344.27K
2026-06-30Kaye JackSell4.11K$37.00151.96K
2026-06-26Abi-Saab WalidSell1.43K$46.8667.20K
2026-06-25Kapusta Matthew CBuy28.72K$31.71910.58K
2026-06-25Kapusta Matthew CSell28.72K$50.021.44M
2026-06-25Kapusta Matthew CSell28.72K$31.71910.58K
2026-06-24Kapusta Matthew CBuy4.13K$31.71130.90K
2026-06-24Kapusta Matthew CSell6.70K$50.00334.80K
2026-06-24Kapusta Matthew CSell4.13K$31.71130.90K
2026-06-18Kapusta Matthew CBuy4.66K$31.71147.64K
2026-06-18Kapusta Matthew CSell4.66K$50.00232.80K
2026-06-18Kapusta Matthew CSell37.02K$50.001.85M
2026-06-18Kapusta Matthew CSell4.66K$31.71147.64K
2026-06-17Kapusta Matthew CBuy62.58K$19.391.21M
2026-06-17Kapusta Matthew CSell23.98K$42.611.02M
2026-06-17Kapusta Matthew CSell6.02K$43.70263.21K
2026-06-17Kapusta Matthew CSell32.58K$45.021.47M
2026-06-17Kapusta Matthew CSell56.93K$43.432.47M
2026-06-17Kapusta Matthew CSell33.33K$45.011.50M
2026-06-17Kapusta Matthew CSell11.59K$48.65563.61K
2026-06-17Kapusta Matthew CSell62.58K$19.391.21M
2026-06-17Balachandran MadhavanBuy6.39K$19.39123.90K
2026-06-17Balachandran MadhavanSell5.29K$47.08249.29K
2026-06-17Balachandran MadhavanBuy5.29K$31.71167.90K
2026-06-17Balachandran MadhavanSell4.70K$43.66205.20K
2026-06-17Balachandran MadhavanSell1.69K$42.6071.99K
2026-06-17Balachandran MadhavanSell5.29K$31.71167.90K
2026-06-17Balachandran MadhavanSell6.39K$19.39123.90K
2026-06-17Kaye JackBuy5.29K$31.71167.90K
2026-06-17Kaye JackSell5.29K$42.57225.41K
2026-06-17Kaye JackSell5.29K$31.71167.90K
2026-06-15Balachandran MadhavanBuy10.00K$8.4984.90K
2026-06-15Balachandran MadhavanSell10.00K$27.85278.50K
2026-06-15Balachandran MadhavanSell10.00K$8.4984.90K
2026-06-15Potts JeannetteSell5.24K$27.67144.91K
2026-06-11Meek David D.Sell1.99K$27.0653.93K
2026-06-11Gut RobertSell2.73K$27.0673.77K
2026-06-11O'Keefe KylieSell15.94K$27.06431.23K
2026-06-11Springhorn Jeremy P.Sell1.99K$27.0653.93K
2026-06-11POST LEONARD ESell1.99K$27.0653.93K
2026-06-11Kaye JackSell1.99K$27.0653.93K
2026-06-11Jacques Rachelle SuzanneSell1.99K$27.0653.93K
2026-06-11Balachandran MadhavanSell1.99K$27.0653.93K
2026-06-10Meek David D.Buy7.55K——
2026-06-10Meek David D.Buy13.98K$26.82374.94K
2026-06-10Gut RobertBuy2.65K$16.0442.43K
2026-06-10Gut RobertBuy7.55K——
2026-06-10Gut RobertSell2.65K$26.0768.96K
2026-06-10Gut RobertSell3.13K$26.0381.40K
2026-06-10Gut RobertSell1.78K$26.0546.37K
2026-06-10Gut RobertBuy13.98K$26.82374.94K
2026-06-10Gut RobertSell2.65K$16.0442.43K
2026-06-10Springhorn Jeremy P.Buy7.55K——
2026-06-10Springhorn Jeremy P.Buy13.98K$26.82374.94K
2026-06-10POST LEONARD EBuy7.55K——
2026-06-10POST LEONARD EBuy13.98K$26.82374.94K
2026-06-10Kaye JackBuy7.55K——
2026-06-10Kaye JackBuy13.98K$26.82374.94K
2026-06-10Jacques Rachelle SuzanneBuy7.55K——
2026-06-10Jacques Rachelle SuzanneBuy13.98K$26.82374.94K
2026-06-10Balachandran MadhavanBuy7.55K——
2026-06-10Balachandran MadhavanBuy13.98K$26.82374.94K
2026-06-03Kaye JackBuy2.65K$16.0442.43K
2026-06-03Kaye JackSell2.65K$30.0179.38K
2026-06-03Kaye JackSell2.65K$16.0442.43K
2026-05-08Abi-Saab WalidBuy25.00K$5.59139.75K
2026-05-08Abi-Saab WalidSell25.00K$25.10627.50K
2026-05-08Abi-Saab WalidSell20.00K$25.00500.00K
2026-05-08Abi-Saab WalidSell25.00K$5.59139.75K
2026-03-04O'Keefe KylieBuy19.80K——
2026-03-04O'Keefe KylieBuy31.90K$9.04288.38K
2026-03-04Kapusta Matthew CBuy70.60K——
2026-03-04Kapusta Matthew CSell14.58K$9.06132.10K
2026-03-04Kapusta Matthew CBuy113.80K$9.041.03M
2026-03-04Abi-Saab WalidBuy41.70K——
2026-03-04Abi-Saab WalidSell808$9.067.32K
2026-03-04Abi-Saab WalidBuy67.20K$9.04607.49K
2026-03-04Potts JeannetteBuy35.40K——
2026-03-04Potts JeannetteSell3.41K$9.0630.91K
2026-03-04Potts JeannetteBuy57.20K$9.04517.09K
2026-03-04KLEMT CHRISTIANBuy39.60K——
2026-03-04KLEMT CHRISTIANSell12.00K$9.06108.72K
2026-03-04KLEMT CHRISTIANBuy63.90K$9.04577.66K
2026-03-02Kapusta Matthew CSell34.44K$9.95342.65K
2026-03-02KLEMT CHRISTIANSell12.53K$9.95124.69K
2026-03-02Potts JeannetteSell8.58K$9.9585.35K
2026-03-02Abi-Saab WalidSell1.66K$9.9516.52K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 302, holders +42 vs prior quarter. Ownership 99.33%.

HolderSharesChangeChange %Value
AVORO CAPITAL ADVISORS LLC6.73M768.18K+12.89%309.88M
JPMORGAN CHASE & CO4.87M2.03M+71.55%230.81M
RTW INVESTMENTS, LP3.94M1.36M+52.40%181.55M
STATE STREET CORP2.90M643.31K+28.46%133.75M
ABERDEEN GROUP PLC2.85M-2.46M-46.33%131.18M
SUSQUEHANNA INTERNATIONAL GROUP, LLP2.58M2.02M+359.07%118.73M
BLACKROCK, INC.1.88M144.00K+8.31%86.48M
ORBIMED ADVISORS LLC1.81M-328.66K-15.39%83.25M
CAPTION MANAGEMENT, LLC1.63M1.34M+458.16%74.97M
JANE STREET GROUP, LLC1.61M1.45M+889.24%74.18M
JENNISON ASSOCIATES LLC1.56M327.62K+26.55%71.92M
BOXER CAPITAL MANAGEMENT, LLC1.50M841.30K+127.08%69.24M
GOLDMAN SACHS GROUP INC1.48M212.72K+16.84%67.98M
TWO SIGMA INVESTMENTS, LP1.46M-1.21M-45.36%67.34M
TWO SEAS CAPITAL LP1.44M141.41K+10.88%66.39M
FMR LLC1.27M-473.74K-27.17%58.50M
MAK CAPITAL ONE LLC1.23M790.85K+179.25%56.75M
MPM BIOIMPACT LLC1.23M-143.38K-10.47%56.46M
MORGAN STANLEY1.07M700.52K+191.34%49.13M
CITADEL ADVISORS LLC1.00M595.63K+147.23%46.07M
VESTAL POINT CAPITAL, LP935.00K576.00K+160.45%43.07M
MAVERICK CAPITAL LTD925.38K227.74K+32.64%42.62M
CITADEL ADVISORS LLC910.34K505.77K+125.02%41.93M
FIERA CAPITAL CORP909.14K92.25K+11.29%41.88M
INTEGRAL HEALTH ASSET MANAGEMENT, LLC900.00K00.00%41.45M

Earnings and financials

uniQure N.V. (QURE) trades at $25.65, with a market cap of $1.78B and a trailing P/E of -6.18. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2016201720182019202020212022202320242025
250980001310700011284000728100037514000524002000106483000158430002711900016098000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

uniQure (QURE) Financials: Revenue & Earnings

QURE$25.65+0.68 +2.72%

$1.78B

Market Cap

-6.18

P/E

24.53

Forward P/E

63

Score

Price History